The latest update is out from ELEVAI Labs Inc. (ELAB).
Elevai Labs Inc. faces a challenge as it has fallen below Nasdaq’s minimum bid price requirement, prompting a notice from Nasdaq that could lead to delisting if not rectified. The company has 180 days to boost its stock price above $1 for at least 10 consecutive days to maintain its listing. Meanwhile, the board undergoes changes with Crystal Muilenburg stepping down and George Kovalyov stepping in, receiving an incentive package including stock options for his new role as chairman of the Compensation Committee.
For detailed information about ELAB stock, go to TipRanks’ Stock Analysis page.
